Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9562 |
High Similarity |
NPD7266 |
Discontinued |
0.8658 |
High Similarity |
NPD1653 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8282 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8272 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8272 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8261 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8239 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8026 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7945 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7881 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD37 |
Approved |
0.7812 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7812 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7812 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7676 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7544 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD228 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7423 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7345 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7261 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD1933 |
Approved |
0.716 |
Intermediate Similarity |
NPD3686 |
Approved |
0.716 |
Intermediate Similarity |
NPD3687 |
Approved |
0.716 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7133 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7093 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7079 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7079 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD5762 |
Approved |
0.707 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7044 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7 |
Intermediate Similarity |
NPD3022 |
Approved |
0.6988 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6981 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4237 |
Approved |
0.6981 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5401 |
Approved |
0.6972 |
Remote Similarity |
NPD5535 |
Approved |
0.697 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD447 |
Suspended |
0.6962 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6952 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6948 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6946 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6943 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6943 |
Remote Similarity |
NPD5588 |
Approved |
0.6943 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5126 |
Approved |
0.6939 |
Remote Similarity |
NPD4626 |
Approved |
0.6937 |
Remote Similarity |
NPD3750 |
Approved |
0.6937 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD3225 |
Approved |
0.6929 |
Remote Similarity |
NPD2684 |
Approved |
0.6928 |
Remote Similarity |
NPD7411 |
Suspended |
0.6918 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD6799 |
Approved |
0.6905 |
Remote Similarity |
NPD5353 |
Approved |
0.6903 |
Remote Similarity |
NPD4140 |
Approved |
0.6875 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6871 |
Remote Similarity |
NPD5691 |
Approved |
0.6864 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6855 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6852 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD6273 |
Approved |
0.6828 |
Remote Similarity |
NPD6671 |
Approved |
0.6821 |
Remote Similarity |
NPD8651 |
Approved |
0.6815 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6813 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6809 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD9545 |
Approved |
0.68 |
Remote Similarity |
NPD1608 |
Approved |
0.6792 |
Remote Similarity |
NPD6032 |
Approved |
0.6792 |
Remote Similarity |
NPD2438 |
Suspended |
0.6791 |
Remote Similarity |
NPD6779 |
Approved |
0.6791 |
Remote Similarity |
NPD6776 |
Approved |
0.6791 |
Remote Similarity |
NPD6782 |
Approved |
0.6791 |
Remote Similarity |
NPD6781 |
Approved |
0.6791 |
Remote Similarity |
NPD6777 |
Approved |
0.6791 |
Remote Similarity |
NPD6778 |
Approved |
0.6791 |
Remote Similarity |
NPD6780 |
Approved |
0.6788 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6788
|
Remote Similarity |
NPD7783 |
Phase 2 |